Invitrogen and Waters Gain After JPMorgan Presentations; Thermo Falls
Shares in Invitrogen and Waters Corporation closed up on Tuesday as company officers presented a positive outlook early in the week at the annual JPMorgan Healthcare Conference in San Francisco this week.
Invitrogen’s shares were up 1.5 percent for the five-day period tracked by the BioCommerce Week Index, while Waters jumped 4.8 percent for the same period.
Thermo Electron, which presented to the conference on Tuesday afternoon, saw its shares fall 1.6 percent.
Becton Dickinson, Applied Biosystems, PerkinElmer, and Agilent Technologies were to present at the conference on Wednesday, while Beckman Coulter and Bio-Rad Laboratories were slated to present on Thursday.
For the week, Stratagene saw its shares drop 11 percent, erasing last week’s gain of 10 percent, followed by Agilent, Bruker, and PerkinElmer with share-price losses of 4 percent.
After two weeks of losses, the BioCommerce Week Index closed up a fraction of a percent at 34.22 as seven of the 15 companies saw share-price gains.
Overall, the index outperformed the Dow, which finished down a fraction of a percent for the week; the S&P 500, which dropped by a half a percentage for the same period; the Nasdaq index, which was down just over 1 percent; and the Amex pharma index, which was down close to 1 percent. The Amex biotechnology index was up 1 percent.
Upcoming Financial Conferences:
- Needham Growth Conference,
Jan. 11-15 (New York City)
Jan. 13: Thermo Electron - PiperJaffray Healthcare,
Jan. 25-27 (New York City)
Jan. 25: Beckman Coulter
Jan. 26: Invitrogen.
Jan. 27: Becton Dickinson, Applied Biosystems. - Merrill Lynch 2005 Global Drug, Device and Biotechnology Conference,
Feb. 8-10 (New York City) - Biotechnology Industry Organization CEO and Investor Conference,
Feb. 23-24 (New York City) - Lehman Brothers’ Global Healthcare Conference,
Mar. 30 — Apr. 1 (Miami Beach, Fla.)
